Genetic Associations with Brushite Kidney Stone Formation
Yes, multiple genes are associated with brushite (calcium-phosphate) kidney stone formation, with genetic variants found in up to 80% of brushite stone formers, particularly genes involved in calcium and phosphate homeostasis such as SLC34A1, CYP24A1, DGKD, CASR, and genes associated with hypophosphatemic rickets.
Key Genetic Findings in Brushite Stone Disease
The most compelling evidence comes from recent genetic testing studies showing that genetic variants are remarkably common in brushite stone formers 1. In a 2025 prospective study, 80% of brushite stone formers had identifiable genetic variants, with 40% having multiple variants and 67% carrying variants associated with hypophosphatemic rickets 1. This high prevalence strongly suggests an intrinsic genetic contribution to brushite stone formation.
Primary Genes Implicated
The following genes have been identified through genome-wide association studies and functional validation 2:
- SLC34A1: Encodes a sodium-phosphate cotransporter critical for renal phosphate handling 2, 3
- CYP24A1: Involved in vitamin D metabolism and calcium homeostasis 2
- DGKD: Plays a role in maintaining calcium and phosphate homeostasis 2
- CASR: Calcium-sensing receptor gene involved in calcium regulation 3
- ALPL: Alkaline phosphatase gene affecting phosphate metabolism 3
- TRPV5: Calcium channel involved in renal calcium reabsorption 3
Clinical Implications for Genetic Testing
According to the 2025 European Association of Urology guidelines, genetic testing should be considered for brushite stone formers who meet specific criteria 4:
- Children and adults aged ≤25 years
- Adults >25 years with suspected inherited or metabolic disorders
- Patients with recurrent stones (≥2 episodes), bilateral disease, or strong family history
The guidelines emphasize that testing must be combined with metabolic evaluations and genetic counseling, with family screening offered when a genetic diagnosis is confirmed 4.
Pathophysiologic Context
The genetic architecture of brushite stone disease reflects its distinct pathophysiology. Brushite stones have higher recurrence rates than calcium oxalate stones and are associated with specific urinary abnormalities including hypercalciuria (84.6%), elevated urine pH (61.5%), and hyperphosphaturia (43.1%) 5. Notably, 50% of brushite stone formers demonstrate distal renal tubular acidosis (dRTA), which may have genetic underpinnings 5.
Variants of Unknown Significance
A critical caveat: 60% of brushite stone formers harbor variants of unknown significance (VUS) 1. This high rate of VUS means that while genetic variants are common, their pathogenic role remains uncertain in many cases. Further research is needed to clarify which variants directly contribute to stone formation versus being incidental findings.
Heritability and Polygenic Factors
Beyond monogenic causes, kidney stone disease shows substantial heritability (45-56%) 4, 6. While monogenic forms account for 12-21% of children/young adults and 1-11% of adults with nephrolithiasis 4, most brushite stone formers likely have polygenic disease involving multiple genetic loci interacting with environmental factors 6.
Important Clinical Pitfall
Do not assume that absence of a known pathogenic variant excludes genetic contribution—the high prevalence of VUS and polygenic inheritance patterns mean that genetic factors may still be operative even when testing is "negative" for known pathogenic variants 1.